Drawing for CMYC

USPTO serial 79306781

CMYC

Reviewed by CopyMark Law Group

Reg. 6756312Status 700Registered
Filing date
Status date
Registration date
Jun 14, 2022
Examiner
GAINES, LEAH R
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CMYC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa A. Ferrari

Lisa A. Ferrari Cozen O'Connor175 Greenwich Street, 55th Floor3 World Trade CenterNew York, NY 10007

Goods and services

ClassDescriptionStatusFirst use
001Chemical substances for analyses in laboratories other than for medical or veterinary purposes; Chemical preparations in the nature of filtering materials for analytical testing and assessment of blood for identifying acute coronary syndromes for use in science, except for medical purposes; diagnostic preparations used in science, except for medical purposes; chemical products, namely, reagent strips in the nature of reagent bearing test strips for testing blood for use in science, except for medical purposes; chemical reagents for use in diagnostic tests for scientific purposes; biological preparations for use in science and manufacturingACTIVE—
005Pharmaceutical products for diagnosing and treating acute coronary syndromes such as myocardial infarction heart attacks; diagnostic preparations for medical purposes; antibodies for medical purposes for the treatment of acute coronary syndromes such as myocardial infarction heart attacks; diagnostic agents and substances and preparations for medical purposes; biological preparations for the treatment of acute coronary syndromes such as myocardial infarction heart attacks for medical purposes; chemical test reagents for medical purposes; chemical preparations for pharmaceutical purposes, namely, for the treatment of acute coronary syndromes such as myocardial infarction heart attacks; chemical preparations for medical purposes, namely, for the treatment of acute coronary syndromes such as myocardial infarction heart attacks; diagnostic chemical reagents for medical purposes; chemical reagents for medical purposes; chemical preparations for testing blood for medical purposesACTIVE—
010Medical diagnostic apparatus and instruments for use in medical analysis of body fluids; blood testing apparatus; medical diagnostic apparatus and instruments for diagnostic radiopharmaceutical use; structural parts and fittings for the aforesaid goodsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 17, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 26, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 26, 2022FIMPFINAL DISPOSITION PROCESSED—
Sep 14, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 14, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 14, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 29, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 29, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 27, 2022GPNXNOTIFICATION PROCESSED BY IB—
Mar 9, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 9, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 9, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 22, 2022ALIEASSIGNED TO LIE—
Feb 22, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 16, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 15, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 15, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 14, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 14, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 2, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 24, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 23, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 23, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 31, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 31, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 31, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 31, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 31, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 13, 2021RFNTREFUSAL PROCESSED BY IB—
Mar 24, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 24, 2021RFRRREFUSAL PROCESSED BY MPU—
Mar 24, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 23, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 19, 2021DOCKASSIGNED TO EXAMINER—
Mar 19, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 18, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance